73063-035-03 : NDC 2026 Code

73063-035-03 : Sodium Phenylbutyrate/taurursodiol ( Relyvrio )

Additionally :

You can get information about “73063-035-03” NDC code in 73063-035-03 in HTML format

HTML | 73063-035-03 in TXT (Plain Text) format

TXT | 73063-035-03 in PDF (Portable Document Format)

PDF | 73063-035-03 in XML format

XML formats.

NDC Code : 73063-035-03 – JSON Data Format

                
{
  "NDC": {
    "NDCCode": "73063-035-03",
    "PackageDescription": "56 POWDER, FOR SUSPENSION in 1 CARTON (73063-035-03) ",
    "NDC11Code": "73063-0035-03",
    "ProductNDC": "73063-035",
    "ProductTypeName": "HUMAN PRESCRIPTION DRUG",
    "ProprietaryName": "Relyvrio",
    "ProprietaryNameSuffix": null,
    "NonProprietaryName": "Sodium Phenylbutyrate/taurursodiol",
    "DosageFormName": "POWDER, FOR SUSPENSION",
    "RouteName": "ORAL",
    "StartMarketingDate": "20220929",
    "EndMarketingDate": "20250228",
    "MarketingCategoryName": "NDA",
    "ApplicationNumber": "NDA216660",
    "LabelerName": "Amylyx Pharmaceuticals Inc",
    "SubstanceName": "SODIUM PHENYLBUTYRATE; TAURURSODIOL DIHYDRATE",
    "StrengthNumber": "3; 1",
    "StrengthUnit": "g/1; g/1",
    "Pharm_Classes": "Ammonium Ion Binding Activity [MoA], Nitrogen Binding Agent [EPC]",
    "DEASchedule": null,
    "Status": "Deprecated",
    "LastUpdate": "2025-02-28",
    "PackageNdcExcludeFlag": "N",
    "ProductNdcExcludeFlag": "N",
    "ListingRecordCertifiedThrough": null,
    "StartMarketingDatePackage": "20220929",
    "EndMarketingDatePackage": "20250228",
    "SamplePackage": "N"
  }
}